Total
0
Shares
Source: CleanSpace
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • CleanSpace (CSX) shares have plummeted today after the company announced its sales dropped over the March quarter
  • The company has experienced lower sales over the past three months and is now expecting third-quarter sales to reach $7 million
  • Over FY21’s first-half, CleanSpace tabled $39.7 million in revenue — five times greater than the $7.3 million result in the previous corresponding period
  • CleanSpace sys the sales have been impacted by a sudden shift in the North American healthcare procurement market
  • Given the uncertainty, CleanSpace will not provide guidance for the second half of 2021
  • On the market this morning, CleanSpace is down 55.2 per cent and trading at $1.99 per share

CleanSpace (CSX) shares have plummeted today after the company announced its sales dropped over the March quarter.

The respiratory protection equipment developer has experienced lower sales over the current quarter following what it describes as an “exceptional” first-half. Third-quarter sales are now expected to reach $7 million.

Over FY21’s first-half, CleanSpace tabled $39.7 million in revenue — five times greater than the $7.3 million result in the previous corresponding period.

CleanSpace says a shift in the North American healthcare procurement market is impacting sales in the short-term. This has been driven by a number of factors, such as vaccine rollout programs, spending constraints and a backlog stockpiling of low-tech disposable masks.

Nevertheless, the company maintains it has a strong U.S. hospital pipeline supporting sales in the medium- and long-term.

Additionally, U.S. President Biden’s latest incentive package has introduced a platform for increasing the quality of personal protective equipment and pandemic preparedness for present and future COVID-19 outbreaks.

“With a large total addressable market of $6.3 billion and accelerated investment to penetrate that market, the business is confident it will return to the historical strong growth rates in the medium term,” CleanSpace told the market.

“Large employers, including hospital groups, have indicated high satisfaction with the product and we anticipate similar responses as our products roll out further,” he added.

Given the uncertainty, CleanSpace will not provide guidance for the second half of FY21.

On the market this morning, CleanSpace is down 55.2 per cent and trading at $1.99 per share at 12:11 pm AEDT.

CSX by the numbers
More From The Market Herald
APM (ASX:APM) - CEO, Michael Anghie

" APM Human Services (ASX:APM) expands, acquiring Lifecare

APM Human Services International (APM) has acquired physiotherapy and home care group Lifecare for $68 million.
Resonance Health (ASX:RHT)

" Resonance Health (ASX:RHT) submits LiverSmart to FDA

Resonance Health (RHT) has submitted its LiverSmart device to the Food and Drug Administration (FDA) for US regulatory clearance.
Dotz Nano (ASX:DTZ) - CEO, Gideon Shmuel

" Dotz Nano (ASX:DTZ) signs Malaysian distribution deal for COVID-19 tests

Dotz Nano (DTZ) has entered into a distribution agreement with ScienceVision to promote, sell and distribute its COVID-19 virus detection technology in Malaysia.
Kazia Therapeutics (ASX:KZA) - CEO, Dr James Garner

" Kazia Therapeutics (ASX:KZA) releases “positive” second-phase study results for brain cancer treatment

Kazia Therapeutics (KZA) has opened the trading day green after reporting positive final results from a second-phase clinical study of its paxalisib drug